<HashMap><database>biostudies-literature</database><scores><citationCount>0</citationCount><reanalysisCount>0</reanalysisCount><viewCount>47</viewCount><searchCount>0</searchCount></scores><additional><submitter>Newmister SA</submitter><funding>NIDDK NIH HHS</funding><funding>NCI NIH HHS</funding><funding>NIGMS NIH HHS</funding><funding>NIH HHS</funding><pagination>345-351</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5880276</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(4)</volume><pubmed_abstract>Hapalindole alkaloids are a structurally diverse class of cyanobacterial natural products defined by their varied polycyclic ring systems and diverse biological activities. These complex metabolites are generated from a common biosynthetic intermediate by the Stig cyclases in three mechanistic steps: a rare Cope rearrangement, 6-exo-trig cyclization, and electrophilic aromatic substitution. Here we report the structure of HpiC1, a Stig cyclase that catalyzes the formation of 12-epi-hapalindole U in vitro. The 1.5-Å structure revealed a dimeric assembly with two calcium ions per monomer and with the active sites located at the distal ends of the protein dimer. Mutational analysis and computational methods uncovered key residues for an acid-catalyzed [3,3]-sigmatropic rearrangement, as well as specific determinants that control the position of terminal electrophilic aromatic substitution, leading to a switch from hapalindole to fischerindole alkaloids.</pubmed_abstract><journal>Nature chemical biology</journal><pubmed_title>Structural basis of the Cope rearrangement and cyclization in hapalindole biogenesis.</pubmed_title><pmcid>PMC5880276</pmcid><funding_grant_id>S10 OD020011</funding_grant_id><funding_grant_id>F32 GM122218</funding_grant_id><funding_grant_id>R01 DK042303</funding_grant_id><funding_grant_id>R35 GM118101</funding_grant_id><funding_grant_id>S10 OD012289</funding_grant_id><funding_grant_id>R01 CA070375</funding_grant_id><pubmed_authors>Garcia-Borras M</pubmed_authors><pubmed_authors>Sanders JN</pubmed_authors><pubmed_authors>Li S</pubmed_authors><pubmed_authors>Williams RM</pubmed_authors><pubmed_authors>Smith JL</pubmed_authors><pubmed_authors>Yu F</pubmed_authors><pubmed_authors>Lowell AN</pubmed_authors><pubmed_authors>Houk KN</pubmed_authors><pubmed_authors>Newmister SA</pubmed_authors><pubmed_authors>Yang S</pubmed_authors><pubmed_authors>Sherman DH</pubmed_authors><view_count>47</view_count></additional><is_claimable>false</is_claimable><name>Structural basis of the Cope rearrangement and cyclization in hapalindole biogenesis.</name><description>Hapalindole alkaloids are a structurally diverse class of cyanobacterial natural products defined by their varied polycyclic ring systems and diverse biological activities. These complex metabolites are generated from a common biosynthetic intermediate by the Stig cyclases in three mechanistic steps: a rare Cope rearrangement, 6-exo-trig cyclization, and electrophilic aromatic substitution. Here we report the structure of HpiC1, a Stig cyclase that catalyzes the formation of 12-epi-hapalindole U in vitro. The 1.5-Å structure revealed a dimeric assembly with two calcium ions per monomer and with the active sites located at the distal ends of the protein dimer. Mutational analysis and computational methods uncovered key residues for an acid-catalyzed [3,3]-sigmatropic rearrangement, as well as specific determinants that control the position of terminal electrophilic aromatic substitution, leading to a switch from hapalindole to fischerindole alkaloids.</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Apr</publication><modification>2024-11-07T06:39:59.675Z</modification><creation>2019-06-06T19:15:51Z</creation></dates><accession>S-EPMC5880276</accession><cross_references><pubmed>29531360</pubmed><doi>10.1038/s41589-018-0003-x</doi></cross_references></HashMap>